dr. bekaii-saab reflects on the findings of the redos trial in mcrc
Published 6 years ago • 55 plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
0:57
dr. bekaii-saab on the importance of the redos study in mcrc
-
2:27
dr. bekaii-saab on the redos study in metastatic colorectal cancer
-
1:20
dr. bekaii-saab on the use of regorafenib in patients with mcrc
-
1:42
dr. bekaii-saab discusses the redos study in metastatic crc
-
1:16
dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
0:20
copy of dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
1:21
dr. bekaii-saab discusses regorafenib use in mcrc
-
0:56
dr. bekaii-saab on tolerability of encorafenib, binimetinib, and cetuximab in braf crc
-
6:30
psoriasis is an autoimmune disease that can be healed naturally using functional medicine
-
49:08
9 sept 2021-bicara dr-dermatitis atopik-bukan sekadar penyakit kulit
-
3:58
microbiome in psoriasis, e.a. langan et al
-
1:39
dr. bekaii-saab on dosing strategies with regorafenib in crc
-
5:53
redos trial: optimizing regorafenib dosing in metastatic colorectal cancer
-
2:11
expert reviews redos trial results in mcrc
-
0:57
dr. bekaii-saab discusses the next steps with regorafenib in crc
-
1:20
tanios bekaii-saab, md: clinical data supporting regorafenib in mcrc
-
1:27
tanios bekaii-saab, md, comments on dosing regorafenib (stivarga) in 3rd line treatment of mcrc
-
2:26
dr. bekaii-saab on the impact of regorafenib in crc
-
2:24
dr. bekaii saab compares toxicities of regorafenib and tas-102 in colorectal cancer
-
2:22
dr. tanios bekaii-saab on new agents to treat colorectal cancer
-
1:12
tanios bekaii-saab, md: mechanisms of action in regorafenib
-
1:50
dr. bekaii-saab on sequencing regorafenib and tas-102 in crc